Koers PHOX BIOT26 Nasdaq
Aandelen
PBAXU
US71902K2042
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 68,71 mln. 64,26 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | -2 mln. -1,87 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 174K 163K | Nettoschuld 2023 | 1,46 mln. 1,36 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-346
x | K/w-verhouding 2023 |
-28,3
x | Werknemers | 9 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 64,78% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,31% | 103 mld. | |
+0,56% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,37% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-14,85% | 15,52 mld. | |
+3,21% | 13,86 mld. | |
+33,54% | 12,04 mld. |